The Association of Bifidobacterium breve BR03 and B632 is Effective to Prevent Colics in Bottle-fed Infants: A Pilot, Controlled, Randomized, and Double-Blind Study
| Autor: | Sheila Beux, Simonetta Bellone, Mario Del Piano, Flavia Prodam, Gianni Bona, Diana Di Gioia, Alessia Pagani, Sonia Monticone, Enza Giglione, Giovanni Mogna, Agostina Marolda |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Male
Pediatrics medicine.medical_specialty Colic ved/biology.organism_classification_rank.species Pilot Projects Crying Bifidobacterium breve Placebo law.invention Double blind study 03 medical and health sciences Probiotic 0302 clinical medicine Randomized controlled trial Double-Blind Method law 030225 pediatrics medicine Humans ved/biology business.industry Probiotics Gastroenterology Infant Bottle fed Bottle Feeding Gastrointestinal Microbiome Breast Feeding Treatment Outcome 030211 gastroenterology & hepatology Female medicine.symptom business Breast feeding |
| Zdroj: | Journal of clinical gastroenterology. |
| ISSN: | 1539-2031 |
| Popis: | Goals To assess the effectiveness of Bifidobacterium breve B632 and BR03 association in the reduction of infants crying over time. The second endpoint was to observe the effect of the same strains on daily evacuations and on the number of regurgitations and vomits. Background Infant colics represent a clinical condition in childhood, characterized by an uncontrollable crying that occurs without any apparent organic cause. An altered intestinal microbiota composition in the very first months may induce intestinal colics in infants. Thus far, no treatment is really effective for this problem, but recent literature shows an increasing attention toward probiotics. Study A total of 83 subjects were enrolled, 60 breastfed infants and 23 bottle-fed infants. Sixty of them carried out the study: 29 infants were given probiotics, whereas 31 placebo. During the 90 days of the study, parents were asked to give 5 drops of active product (10 viable cells/strain) or placebo and to daily take note of: minutes of crying, number, color, and consistency of evacuations, and number of regurgitations or vomits. Results No significant differences were detected in the infants treated with probiotics, compared with placebo group (P=0.75). The analysis of the 3 months of treatment demonstrated that during the third month, the probiotic group cried 12.14 minutes on average and the placebo cried 46.65 minutes. This difference is statistically significant (P=0.016). Conclusions The evidence of the usefulness of some probiotic strains in the treatment and prevention of infant colics is growing, and therefore their use in clinical practice is spreading. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|